| Title | Author(s) | Year | View Count |  | A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy | Wong, ICK; Mawer, GE; Sander, JWAS; Lhatoo, SD | 2001 | 116 |
| Adverse event monitoring in lamotrigine patients: A pharmacoepidemiologic study in the United Kingdom | Wong, ICK; Mawer, GE; Sander, JWAS | 2001 | 125 |
| Long-term treatment retention with topiramate [4] (multiple letters) | Deckers, CLP; Renier, WO; Lhatoo, SD; Sander, JWAS; Wong, ICK | 2001 | 64 |
| Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults [2] (multiple letters) | Lhatoo, SD; Sander, JWAS; Wong, ICK; Aldenkamp, AP; Martin, R; Kuzniecky, R; Hu, S; Hetherington, H; Pen, J; Sinclair, K; Gilliam, F; Fraught, E | 2000 | 90 |
| Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy | Lhatoo, SD; Wong, ICK; Polizzi, G; Sander, JWAS | 2000 | 86 |
| Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy | Lhatoo, SD; Wong, ICK; Sander, JWAS | 2000 | 69 |
| Factors influencing the incidence of lamotrigine-related skin rash | Wong, ICK; Mawer, GE; Sander, JWAS | 1999 | 137 |
| The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy | Wong, ICK; Chadwick, DW; Fenwick, PBC; Mawer, GE; Sander, JWAS | 1999 | 98 |
| Severe persistent visual field constriction associated with vigabatrin (multiple letters) [7] | Wilson, EA; Brodie, MJ; Wong, IC; Mawer, GE; Sander, JWAS; Blackwell, N; Hayllar, J; Kelly, G; Harding, GFA; Backstrom, JT; Hinkle, RL; Flicker, MR | 1997 | 67 |
|
